A Nanocomposite Dynamic Covalent Cross-Linked Hydrogel Loaded with Fusidic Acid for Treating Antibiotic-Resistant

Samaneh Toufanian1, Jody Mohammed2, Erica Winterhelt3

  • 1Department of Chemical Engineering, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4L8, Canada.

ACS Applied Bio Materials
|February 23, 2024
PubMed

Insights

A novel hydrogel loaded with fusidic acid nanoparticles effectively treats MRSA skin infections. This approach improves local drug delivery and reduces antibiotic dosage for better wound care outcomes.

Area of Science:

  • Biomaterials Science
  • Infectious Diseases
  • Drug Delivery Systems

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) infections cause significant morbidity and are challenging to treat.
  • Many new antibiotics have poor solubility, limiting their effectiveness via standard administration routes.
  • Existing treatments like fusidic acid (FA) could be improved with alternative delivery methods for better local efficacy.

Purpose of the Study:

  • To develop an advanced wound dressing for treating MRSA infections.
  • To overcome challenges in delivering hydrophobic antimicrobial drugs locally.
  • To enhance the bioavailability and reduce the dosage of fusidic acid for skin wound treatment.

Main Methods:

  • Fabrication of a poly(oligoethylene glycol methacrylate) (POEGMA) composite hydrogel.
  • Encapsulation of fusidic acid (FA) within polylactic acid-b-poly(oligo(ethylene glycol) methyl ether methacrylate) (PLA-POEGMA) nanoparticles.
  • Loading of FA-encapsulating nanoparticles into the hydrogel for sustained release (approx. 10 hours).
  • Evaluation of hydrogel mechanical properties and stability.
  • In vitro and in vivo assessment of antimicrobial activity against MRSA in a murine wound model.

Main Results:

  • The composite hydrogel maintained favorable mechanical properties and stability.
  • Fusidic acid was released via a diffusion-controlled mechanism over ~10 hours.
  • Demonstrated significant in vitro zones of inhibition against MRSA.
  • Achieved 1-2 orders of magnitude reduction in bacterial growth in vivo in MRSA-infected wounds.
  • Effective treatment was observed even at very low antibiotic doses.

Conclusions:

  • The developed POEGMA hydrogel loaded with FA-encapsulating nanoparticles is a promising strategy for MRSA wound infections.
  • This approach effectively delivers hydrophobic antimicrobials locally, improving efficacy and reducing required drug dosage.
  • The system circumvents bioavailability issues associated with poorly soluble antibiotics.

Related Concept Videos

Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
3.0K
Microbial Corrosion01:24

Microbial Corrosion

Microbiologically Influenced Corrosion (MIC) is a significant form of material degradation caused by the metabolic activities of microorganisms. This phenomenon poses substantial challenges across various industries, including oil and gas, maritime, and water treatment sectors.MIC occurs when microorganisms, such as bacteria, archaea, and fungi, colonize metal surfaces, forming biofilms that alter the local electrochemical environment. These biofilms can lead to the production of corrosive...
93
iChip01:24

iChip

The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...
105
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
143
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90